Related references
Note: Only part of the references are listed.Immune evasion in renal cell carcinoma: biology, clinical translation, future directions
Xiaoyang Wang et al.
KIDNEY INTERNATIONAL (2021)
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing
Junpeng Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Increased chromosomal instability characterizes metastatic renal cell carcinoma
Qin Ma et al.
TRANSLATIONAL ONCOLOGY (2021)
Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications
Qinhan Li et al.
FRONTIERS IN GENETICS (2021)
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival
Shaan Dudani et al.
JAMA NETWORK OPEN (2021)
Tumor-Associated Microbiome: Where Do We Stand?
Marc Oliva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A dual drug therapy for sunitinib resistant RCC: An in vitro analysis.
Jacob W. Greenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
Brusabhanu Nayak et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries
Tejeshwar Jain et al.
FRONTIERS IN IMMUNOLOGY (2021)
Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
Sona Ciernikova et al.
CANCERS (2021)
Identification of a Gene Signature for Renal Cell Carcinoma-Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis
Bitian Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Machine Learning Approach to Predict the Probability of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study
HyungMin Kim et al.
JMIR MEDICAL INFORMATICS (2021)
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
Zhigang Ren et al.
GUT (2021)
Development and evaluation of a deep neural network for histologic classification of renal cell carcinoma on biopsy and surgical resection slides
Mengdan Zhu et al.
SCIENTIFIC REPORTS (2021)
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zheying Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Does drug dispensing improve the health outcomes of patients attending community pharmacies? A systematic review
Barbara Pizetta et al.
BMC HEALTH SERVICES RESEARCH (2021)
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Revati Sharma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
Jinbo Song et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer
David Jacobson et al.
PeerJ (2021)
A Multisite Study of a Breast Density Deep Learning Model for Full-Field Digital Mammography and Synthetic Mammography
Thomas P. Matthews et al.
RADIOLOGY-ARTIFICIAL INTELLIGENCE (2021)
Prediction of chemoresistance trait of cancer cell lines using machine learning algorithms and systems biology analysis
Atousa Ataei et al.
JOURNAL OF BIG DATA (2021)
Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota
Ting-Ting Gong et al.
JOURNAL OF CANCER (2021)
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions
Peio Errarte et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma
Andres F. Correa et al.
CANCER BIOLOGY & THERAPY (2020)
Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging
Ianto Lin Xi et al.
CLINICAL CANCER RESEARCH (2020)
Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
Anubhab Mukherjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study
Alejandro Sanchez et al.
LANCET ONCOLOGY (2020)
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type
Qi Cai et al.
EBIOMEDICINE (2020)
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe et al.
FRONTIERS IN ONCOLOGY (2020)
Tumor Targeting by αvβ3-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
Alexandros Marios Sofias et al.
ACS NANO (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Genomic and transcriptomic correlates of clinical benefit from immunotherapy and targeted therapy among patients with metastatic renal cell carcinoma (mRCC).
Nicholas Salgia et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Hypoxia-Responsive Polypeptide Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
Peng Zhang et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma
Praful Ravi et al.
JAMA ONCOLOGY (2020)
Proteomic approaches for characterizing renal cell carcinoma
David J. Clark et al.
CLINICAL PROTEOMICS (2020)
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Alessandra Raimondi et al.
FRONTIERS IN ONCOLOGY (2020)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors
Nicholas J. Salgia et al.
EUROPEAN UROLOGY (2020)
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma
Izak Faiena et al.
JOURNAL OF IMMUNOTHERAPY (2020)
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai et al.
NATURE IMMUNOLOGY (2020)
Radiomics and Artificial Intelligence for Renal Mass Characterization
Meghan G. Lubner
RADIOLOGIC CLINICS OF NORTH AMERICA (2020)
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
Rouven Hoefflin et al.
NATURE COMMUNICATIONS (2020)
A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response
A. Ari Hakimi et al.
NATURE COMMUNICATIONS (2020)
Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Hong Zhi et al.
FRONTIERS IN ONCOLOGY (2020)
Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
Martin J. Bergman et al.
RHEUMATOLOGY AND THERAPY (2020)
The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review
Tomoyuki Fujioka et al.
DIAGNOSTICS (2020)
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma
Weiqiang Xu et al.
MEDICINE (2020)
Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
Harini Lakshminarayanan et al.
FRONTIERS IN ONCOLOGY (2020)
Artificial Intelligence in Renal Mass Characterization: A Systematic Review of Methodologic Items Related to Modeling, Performance Evaluation, Clinical Utility, and Transparency
Burak Kocak et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population
F. Z. Bensouilah et al.
AFRICAN JOURNAL OF UROLOGY (2020)
Epidemiology of Renal Cell Carcinoma
Sandeep Anand Padala et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Microbiome within Primary Tumor Tissue from Renal Cell Carcinoma May Be Associated with PD-L1 Expression of the Venous Tumor Thrombus
Michael A. Liss et al.
ADVANCES IN UROLOGY (2020)
Preparation of HR magnetic IONPs for drug delivery
Zhongping Chen et al.
MICRO & NANO LETTERS (2019)
Predicting drug response of tumors from integrated genomic profiles by deep neural networks
Yu-Chiao Chiu et al.
BMC MEDICAL GENOMICS (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma
David D. Stenehjem et al.
PLOS ONE (2019)
Chimeric antigen receptor T-cell therapy: Foundational science and clinical knowledge for pharmacy practice
Anna Dushenkov et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Microbiome and Cancers, With Focus on Genitourinary Tumors
Alessia Cimadamore et al.
FRONTIERS IN ONCOLOGY (2019)
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Brian I. Rini et al.
LANCET (2019)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
David A. Braun et al.
JAMA ONCOLOGY (2019)
Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database
Bin Chen et al.
DISEASE MARKERS (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts
Yi Li et al.
ACTA BIOMATERIALIA (2019)
Genomic Information for Clinicians in the Electronic Health Record: Lessons Learned From the Clinical Genome Resource Project and the Electronic Medical Records and Genomics Network
Marc S. Williams et al.
FRONTIERS IN GENETICS (2019)
Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
Marta Tellez-Gabriel et al.
CANCERS (2019)
Role of the intestinal microbiome in colorectal cancer surgery outcomes
Lelde Lauka et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
Carmine D'Aniello et al.
FRONTIERS IN ONCOLOGY (2019)
Folic Acid-Functionalized, Condensed Magnetic Nanoparticles for Targeted Delivery of Doxorubicin to Tumor Cancer Cells Overexpressing the Folate Receptor
Athina Angelopoulou et al.
ACS OMEGA (2019)
'Multi-omic' data analysis using O-miner
Ajanthah Sangaralingam et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Biomarker-guided trials: Challenges in practice
M. Antoniou et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2019)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision
James J. Hsieh et al.
JOURNAL OF PATHOLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
Enis Afgan et al.
NUCLEIC ACIDS RESEARCH (2018)
Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis
Junqi Liu et al.
Oncotarget (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J. Ricketts et al.
CELL REPORTS (2018)
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
Hashem O. Alsaab et al.
BIOMATERIALS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
AGING-US (2018)
Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers
Sabina Signoretti et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
Alessia Cimadamore et al.
FRONTIERS IN ONCOLOGY (2018)
Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
Shengming Jin et al.
JOURNAL OF CANCER (2018)
Personalised medicine challenges: quality of data
Ricardo Cruz-Correia et al.
INTERNATIONAL JOURNAL OF DATA SCIENCE AND ANALYTICS (2018)
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
Giorgio Stanta et al.
FRONTIERS IN MEDICINE (2018)
The growing role of precision and personalized medicine for cancer treatment
Paulina Krzyszczyk et al.
TECHNOLOGY (2018)
Reply to Ye Lei, Serdar Yildiz, and Minfeng Chen's Letter to the Editor re: James J. Hsieh, David Chen, Patricia Wang, et al. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 2017;71:405-14
James J. Hsieh et al.
EUROPEAN UROLOGY (2017)
Human genomics projects and precision medicine
F. Carrasco-Ramiro et al.
GENE THERAPY (2017)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer
Aurelie Gagnaire et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration
Kwanjeera Wanichthanarak et al.
PLOS ONE (2017)
Breaking Down the Barriers to Precision Cancer Nanomedicine
Christina von Roemeling et al.
TRENDS IN BIOTECHNOLOGY (2017)
Metabolic labeling in middle-down proteomics allows for investigation of the dynamics of the histone code
Simone Sidoli et al.
EPIGENETICS & CHROMATIN (2017)
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review
Bum Jun Kim et al.
ONCOTARGET (2017)
Data, data everywhere: the challenges of personalised medicine
Stephen Armstrong
BMJ-BRITISH MEDICAL JOURNAL (2017)
Transcriptomics technologies
Rohan Lowe et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Data, data everywhere: the challenges of personalised medicine
Stephen Armstrong
BMJ-BRITISH MEDICAL JOURNAL (2017)
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval
Vinay Prasad et al.
JAMA INTERNAL MEDICINE (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges
Lori Knowles et al.
JOURNAL OF LAW AND THE BIOSCIENCES (2017)
Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
Steven A. Mann et al.
CURRENT DRUG METABOLISM (2017)
Cancer nanomedicine: a review of recent success in drug delivery
Stephanie Tran et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
M. H. Voss et al.
ANNALS OF ONCOLOGY (2017)
Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer
Qiwei Yang et al.
BIOMATERIALS (2017)
Circulating tumor cells and CDX models as a tool for preclinical drug development
Alice Lallo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch
H. Scheerens et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma
Shanthini M. Crusz et al.
BMC MEDICINE (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
The prospect of precision therapy for renal cell carcinoma
Chiara Ciccarese et al.
CANCER TREATMENT REVIEWS (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
The sequence of sequencers: The history of sequencing DNA
James M. Heather et al.
GENOMICS (2016)
Untargeted Metabolomics Strategies-Challenges and Emerging Directions
Alexandra C. Schrimpe-Rutledge et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2016)
Coming of age: ten years of next-generation sequencing technologies
Sara Goodwin et al.
NATURE REVIEWS GENETICS (2016)
Precision medicine from the renal cancer genome
Yasser Riazalhosseini et al.
NATURE REVIEWS NEPHROLOGY (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma
Xiang Sun et al.
ONCOLOGY REPORTS (2016)
Osimertinib making a breakthrough in lung cancer targeted therapy
Haijun Zhang
ONCOTARGETS AND THERAPY (2016)
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
Ying-Bei Chen et al.
NATURE COMMUNICATIONS (2016)
Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps
Hong Zheng et al.
ONCOTARGET (2016)
Personalized Medicine in the U.S. and Germany: Awareness, Acceptance, Use and Preconditions for the Wide Implementation into the Medical Standard
Kateryna Kichko et al.
JOURNAL OF PERSONALIZED MEDICINE (2016)
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response
Thai H. Ho et al.
EUROPEAN UROLOGY FOCUS (2016)
Renal cell carcinoma: links and risks
Reena Kabaria et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2016)
Personalized Proteomics: The Future of Precision Medicine
Trevor T. Duarte et al.
PROTEOMES (2016)
Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection
Lucie Sancey et al.
ACS NANO (2015)
Diagnostic Approach to Hereditary Renal Cell Carcinoma
Shiva Gupta et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma
Ben Y. Zhang et al.
EUROPEAN UROLOGY (2015)
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Ariana Znaor et al.
EUROPEAN UROLOGY (2015)
The PI3K/AKT Pathway and Renal Cell Carcinoma
Huifang Guo et al.
JOURNAL OF GENETICS AND GENOMICS (2015)
Imaging Findings of Common Benign Renal Tumors in the Era of Small Renal Masses: Differential Diagnosis from Small Renal Cell Carcinoma - Current Status and Future Perspectives
Sungmin Woo et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Jenny J. Ko et al.
LANCET ONCOLOGY (2015)
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy
Rajesh R. Singh et al.
MODERN PATHOLOGY (2015)
Ethical, legal and social implications of incorporating personalized medicine into healthcare
Kyle B. Brothers et al.
PERSONALIZED MEDICINE (2015)
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
Fleur Weeber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways
Chenchen Feng et al.
SCIENTIFIC REPORTS (2015)
Identification of a Variant in KDR Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib
Michael L. Maitland et al.
CLINICAL CANCER RESEARCH (2015)
Cancer and the microbiome: potential applications as new tumor biomarker
Khan Shahanavaj et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma
Steffen Durinck et al.
NATURE GENETICS (2015)
Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery
Thavasyappan Thambi et al.
BIOMATERIALS (2014)
Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling
A. Atrih et al.
BRITISH JOURNAL OF CANCER (2014)
Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
Robert J. Motzer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non-Small-Cell Lung Cancer
Adam Falconi et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Potential of fecal microbiota for early-stage detection of colorectal cancer
Georg Zeller et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Top-down proteomics in health and disease: Challenges and opportunities
Zachery R. Gregorich et al.
PROTEOMICS (2014)
A pan-cancer proteomic perspective on The Cancer Genome Atlas
Rehan Akbani et al.
NATURE COMMUNICATIONS (2014)
Surgical Management of Renal Cell Carcinoma
Laura-Maria Krabbe et al.
SEMINARS IN INTERVENTIONAL RADIOLOGY (2014)
Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis
Sameh Magdeldin et al.
CLINICAL PROTEOMICS (2014)
Dual growth factor releasing multi-functional nanofibers for wound healing
Zhiwei Xie et al.
ACTA BIOMATERIALIA (2013)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
John R. Srigley et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma
Toni K. Choueiri et al.
CLINICAL CANCER RESEARCH (2013)
Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
M. S. Monteiro et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
TCPA: a resource for cancer functional proteomics data
Jun Li et al.
NATURE METHODS (2013)
Pharmacometabonomics and personalized medicine
Jeremy R. Everett et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence
Changjun Liu et al.
BIOMATERIALS (2012)
Impact of biomarkers on clinical trial risk in breast cancer
Jayson L. Parker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Impact of Genomics on Personalized Cancer Medicine
Carlos L. Arteaga et al.
CLINICAL CANCER RESEARCH (2012)
High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer
C. D'Alterio et al.
CURRENT CANCER DRUG TARGETS (2012)
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE
Francesca Raimondo et al.
MOLECULAR BIOSYSTEMS (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Christine Vogel et al.
NATURE REVIEWS GENETICS (2012)
Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease
E. Jonasch et al.
ANNALS OF ONCOLOGY (2011)
Sequencing technologies and genome sequencing
Chandra Shekhar Pareek et al.
JOURNAL OF APPLIED GENETICS (2011)
Clinical Trial Risk in Non-Hodgkin's Lymphoma: Endpoint and Target Selection
Jayson L. Parker et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2011)
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
Manuel Hidalgo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Toni K. Choueiri et al.
BJU INTERNATIONAL (2010)
Signaling pathways in renal cell carcinoma
Gowrishankar Banumathy et al.
CANCER BIOLOGY & THERAPY (2010)
1H NMR Metabonomic Analysis in Renal Cell Carcinoma: a Possible Diagnostic Tool
Athina N. Zira et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Alterations in VHL as potential biomarkers in renal-cell carcinoma
Lucy Gossage et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Epidemiology and risk factors for kidney cancer
Wong-Ho Chow et al.
NATURE REVIEWS UROLOGY (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
In vivo assembly of nanoparticle components to improve targeted cancer imaging
Steven D. Perrault et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role of cytokine therapy for Renal Cell Carcinoma in the era of targeted agents
Sebastien J. Hotte et al.
Current Oncology (2009)
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Diagnostic yield of renal biopsies: a retrospective single center review
Bari Scheckner et al.
BMC NEPHROLOGY (2009)
Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions
Daniel Y.C. Heng et al.
Therapeutic Advances in Medical Oncology (2009)
Metabonomic profiling of renal cell carcinoma: High-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis
Hongchang Gao et al.
ANALYTICA CHIMICA ACTA (2008)
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
Preetha Anand et al.
BIOCHEMICAL PHARMACOLOGY (2008)
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma
Toni K. Choueiri et al.
JOURNAL OF UROLOGY (2008)
MRI of the basement membrane using charged nanoparticles as contrast agents
Kevin M. Bennett et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
Michelle Longmire et al.
NANOMEDICINE (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
Family history and the risk of kidney cancer: A multicenter case-control study in Central Europe
Rayjean J. Hung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
A comprehensive urinary metabolomic approach for identifying kidney cancer
Tobias Kind et al.
ANALYTICAL BIOCHEMISTRY (2007)
Mass spectrometry-based metabolomics
Katja Dettmer et al.
MASS SPECTROMETRY REVIEWS (2007)
Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme
A. B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Treatment for renal cancer: are we beyond the cytokine era?
Sara Ramsey et al.
NATURE CLINICAL PRACTICE UROLOGY (2006)
Sarcomatoid renal cell carcinoma - An examination of underlying histologic subtype and an analysis of associations with patient outcome
JC Cheville et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Gene expression profiling of renal cell carcinoma
MH Tan et al.
CLINICAL CANCER RESEARCH (2004)
Renal cell carcinoma: current status and future directions
CL Martel et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
I Frank et al.
JOURNAL OF UROLOGY (2002)
Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma:: Relationship to clinicopathological parameters
K Kondo et al.
GENES CHROMOSOMES & CANCER (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Two-dimensional polyacrylamide gel electrophoresis of the protease SP220K, a renal cell carcinoma marker
M Starita-Geribaldi et al.
BIOSEPARATION (2000)
Share Paper
